Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer.
Niu Zh(Qingdao University), Liusheng Wu(Anhui Medical University), Y Wang, Brie Chun(Providence Portland Medical Center), Li Cx
PubMed
May 1, 2013
Cited by 30
Related Papers
Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis
|Biomedicines|2022|121
Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research
|Anti-Cancer Drugs|2022|120